Skip to main content
TipRanks
Go Ultimate75% OFF

TG Therapeutics (TGTX) Ownership - Who Owns TG Therapeutics?

2,176 Followers

TG Therapeutics (TGTX) Ownership Overview

  • 7.63% Insiders
  • 20.04% Mutual Funds
  • 22.08% Other Institutional Investors
  • 27.19% ETFs
  • 23.06% Public Companies and Individual Investors

The ownership structure of TG Therapeutics (TGTX) stock is a mix of institutional, retail, and individual investors. Approximately 69.30% of the company’s stock is owned by Institutional Investors, 7.63% is owned by Insiders, and 23.06% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Sep 13, 2026Laurence Charney$274,800
Nov 24, 2025Yann Echelard$162,850

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Sep 30, 2026 $1,262,576,563

Top Shareholders

TGTX top shareholders
Holder# of SharesType% HoldingValue
BlackRock, Inc.22,634,933Institution14.98%1,460,179,528
Ishares16,056,145Institution10.62%1,035,781,914
Vanguard13,225,478Institution8.75%853,175,586
Vanguard Index Funds10,870,337Institution7.19%701,245,440
Michael S. Weiss9,778,086Insider6.47%630,784,328
Spdr5,500,830Institution3.64%354,858,543
First Trust2,136,354Institution1.41%137,816,197
Fidelity Salem Street Trust1,747,445Institution1.16%112,727,677
Tiaa-cref Funds1,653,525Institution1.09%106,668,898
Fidelity Concord Street Trust1,314,669Institution0.87%84,809,297

Top Mutual Fund Holders

TGTX top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds10,870,337Institution7.19%701,245,440
Fidelity Salem Street Trust1,747,445Institution1.16%112,727,677
Tiaa-cref Funds1,653,525Institution1.09%106,668,898
Fidelity Concord Street Trust1,314,669Institution0.87%84,809,297
Professionally Managed Portfolios1,300,000Institution0.86%83,863,000
Vanguard Explorer Fund1,285,751Institution0.85%82,943,797
T. Rowe Price New Horizons Fund, Inc.1,013,200Institution0.67%65,361,532
Vanguard Scottsdale Funds1,005,360Institution0.67%64,855,774
Manager Directed Portfolios933,712Institution0.62%60,233,761
Vanguard Tax-managed Funds879,130Institution0.58%56,712,676

Top ETF Holders

TGTX top ETF holders
Holder# of SharesType% HoldingValue
iShares Core S&P Small Cap ETF, IJR ETF8,583,036Institution5.68%554,120,804
Vanguard Total Stock Market ETF, VTI ETF4,398,279Institution2.91%245,336,003
iShares Russell 2000 ETF, IWM ETF3,763,691Institution2.49%242,983,891
Vanguard Small-Cap ETF, VB ETF3,099,443Institution2.05%172,886,931
SPDR S&P BIOTECH ETF, XBI ETF2,808,588Institution1.86%184,692,747
First Trust NYSE Arca Biotechnology Index Fund, FBT ETF1,816,385Institution1.20%117,265,816
Vanguard Small-Cap Growth ETF, VBK ETF1,726,942Institution1.14%96,328,825
Vanguard Extended Market ETF, VXF ETF1,597,223Institution1.06%89,093,099
iShares Russell 2000 Growth ETF, IWO ETF1,372,974Institution0.91%88,639,201
SPDR Portfolio S&P 600 Small Cap ETF, SPSM ETF1,300,255Institution0.86%85,504,769

FAQ

Who Owns TG Therapeutics (TGTX)?
According to the latest TipRanks data, approximately 69.30% of the company's stock is held by institutional investors, 7.63% is held by insiders, and 23.06% is held by public companies and individual investors.
What percentage of TG Therapeutics (TGTX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 69.30% of TG Therapeutics (TGTX) stock is held by institutional investors: 20.04% by mutual funds, 27.19% by ETFs and 22.08% by other institutional investors.
What percentage of TG Therapeutics (TGTX) stock is held by retail investors?
According to the latest TipRanks data, approximately 23.06% of TG Therapeutics (TGTX) stock is held by public companies and individual investors.
Who owns the most shares of TG Therapeutics (TGTX)?
BlackRock, Inc. owns the most shares of TG Therapeutics (TGTX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.